Save the Date: Nordic Nanovector ASA to host in-person and virtual R&D Day on 30 November 2021
Oslo, Norway, 4 November 2021 Nordic Nanovector ASA (OSE: NANOV), a clinical stage biotechnology company developing targeted radiopharmaceuticals to extend and improve the lives of patients with haematological cancers, will host an R&D Day on Tuesday, 30 November 2021 at 14:00 CET/ 13:00 GMT/ 08:00 ET. The meeting will be held in person in Oslo and will also be available via live webcast. The meeting, intended for investors and analysts, will provide an overview of the Company’s vision, progress to date, development pipeline and corporate strategy. Presentations will be delivered